Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor

Por um escritor misterioso

Descrição

Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
IJMS, Free Full-Text
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Frontiers The BASDAI Cut-Off for Disease Activity Corresponding
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Long-Term Adherence to Etanercept in Treatment Effectiveness of
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Response to TNF-α-inhibitor (TNFi) treatment as assessed by the
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Changes in disease activity after 12 weeks of anti-TNF-α therapy
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Tumour necrosis factor inhibitors slow radiographic progression in
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Tumor Necrosis Factor–α Promoter −308/238 Polymorphism
Changes of disease activity [(a) ASDAS; (b) BASDAI] for TNF-α inhibitor
Comparative Efficacy of Tumor Necrosis Factor-α Inhibitors in
de por adulto (o preço varia de acordo com o tamanho do grupo)